Literature DB >> 2236046

Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus.

D Papadopoulo1, C Guillouf, H Mohrenweiser, E Moustacchi.   

Abstract

Fanconi anemia (FA) is an inherited human disorder associated with a predisposition to cancer and characterized by anomalies in the processing of DNA cross-links and certain monoadducts. We reported previously that the frequency of psoralen-photoinduced mutations at the HPRT locus is lower in FA cells than in normal cells. This hypomutability is shown here to be associated with an increased frequency of deletions in the HPRT gene when either a mixture of cross-links and monoadducts or monoadducts alone are induced. Molecular analysis of mutants in the HPRT gene was carried out. In normal cells the majority of spontaneous and induced mutants are point mutations whereas in FA deletion mutations predominate. In that case a majority of mutants were found to lack individual exons or small clusters of exons whereas in normal cells large (complete or major gene loss) and small deletions are almost equally represented. Thus we propose that the FA defect lies in a mutagenic pathway that, in normal cells, involves bypassing lesions and subsequent gap filling by a recombinational process during replication.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236046      PMCID: PMC54960          DOI: 10.1073/pnas.87.21.8383

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens.

Authors:  A D Auerbach; S R Wolman
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

3.  Chinese hamster ovary mutant UV-1 is hypomutable and defective in a postreplication recovery process.

Authors:  T D Stamato; L Hinkle; A R Collins; C A Waldren
Journal:  Somatic Cell Genet       Date:  1981-05

4.  Alterations of gene structure in ethyl methane sulfonate-induced mutants of mammalian cells.

Authors:  M Meuth; J E Arrand
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

5.  Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates.

Authors:  E E Furth; W G Thilly; B W Penman; H L Liber; W M Rand
Journal:  Anal Biochem       Date:  1981-01-01       Impact factor: 3.365

6.  [Spontaneous chromosome aberrations in familial panmyelopathy].

Authors:  T M Schroeder; F Anschütz; A Knopp
Journal:  Humangenetik       Date:  1964

7.  Termination sites of the in vitro nick-translation reaction on DNA that had photoreacted with psoralen.

Authors:  J G Piette; J E Hearst
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Fate of photo-induced 8-methoxypsoralen mono-adducts in yeast. Evidence for bypass of these lesions in the absence of excision repair.

Authors:  R Chanet; C Cassier; N Magaña-Schwencke; E Moustacchi
Journal:  Mutat Res       Date:  1983-08       Impact factor: 2.433

9.  Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents.

Authors:  R Ishida; M Buchwald
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

10.  Identification of two complementation groups in Fanconi anemia.

Authors:  G Duckworth-Rysiecki; K Cornish; C A Clarke; M Buchwald
Journal:  Somat Cell Mol Genet       Date:  1985-01
View more
  33 in total

Review 1.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

2.  Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM.

Authors:  Seiki Hirano; Kazuhiko Yamamoto; Masamichi Ishiai; Mitsuyoshi Yamazoe; Masayuki Seki; Nobuko Matsushita; Mioko Ohzeki; Yukiko M Yamashita; Hiroshi Arakawa; Jean-Marie Buerstedde; Takemi Enomoto; Shunichi Takeda; Larry H Thompson; Minoru Takata
Journal:  EMBO J       Date:  2004-12-23       Impact factor: 11.598

3.  MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair.

Authors:  Lorri R Marek; Molly C Kottemann; Peter M Glazer; Allen E Bale
Journal:  DNA Repair (Amst)       Date:  2008-02-06

4.  RAD51D- and FANCG-dependent base substitution mutagenesis at the ATP1A1 locus in mammalian cells.

Authors:  John M Hinz; Salustra S Urbin; Larry H Thompson
Journal:  Mutat Res       Date:  2009-03-18       Impact factor: 2.433

5.  Pairing of pre- and postsynaptic activities in cerebellar Purkinje cells induces long-term changes in synaptic efficacy in vitro.

Authors:  F Crepel; D Jaillard
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

6.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6.

Authors:  F Rosselli; J Sanceau; J Wietzerbin; E Moustacchi
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

7.  Remodeling of DNA replication structures by the branch point translocase FANCM.

Authors:  Kerstin Gari; Chantal Décaillet; Mathieu Delannoy; Leonard Wu; Angelos Constantinou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-08       Impact factor: 11.205

8.  DNA polymerase POLN participates in cross-link repair and homologous recombination.

Authors:  George-Lucian Moldovan; Mahesh V Madhavan; Kanchan D Mirchandani; Ryan M McCaffrey; Patrizia Vinciguerra; Alan D D'Andrea
Journal:  Mol Cell Biol       Date:  2009-12-07       Impact factor: 4.272

9.  Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.

Authors:  J Kevin Hicks; Colleen L Chute; Michelle T Paulsen; Ryan L Ragland; Niall G Howlett; Quentin Guéranger; Thomas W Glover; Christine E Canman
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

10.  Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.

Authors:  Stephen G Grant; Rubina Das; Christina M Cerceo; Wendy S Rubinstein; Jean J Latimer
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.